Precision BioSciences (DTIL) Financial Statements & Analysis

Precision BioSciences Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Precision BioSciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	34.26	68.70	48.73	25.10	115.53	24.29	22.24	10.88	6.48
Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	34.26	68.70	48.73	25.10	115.53	24.29	22.24	10.88	6.48
Operating Expenses
Research & Development	54.17	59.56	53.38	44.07	115.24	94.71	82.42	45.12	20.32
Selling, General & Administrative	32.24	35.30	39.09	43.34	39.67	39.41	27.03	13.67	8.02
Operating Expenses	86.41	94.86	92.46	-87.41	154.91	134.11	109.44	58.80	28.34
Operating Income	-52.15	-26.16	-43.74	112.50	-39.38	-109.83	-87.20	-47.91	-21.97
Other Income/Expense
Interest Income	4.24	6.76	7.69	3.47	0.21	0.82	4.27	1.88	0.87
Interest Expense	1.42	1.78	2.23	-1.11	0.13	0.00	0.18	0.00	0.00
Other Income/Expense	5.54	33.33	-4.25	-10.60	8.70	0.82	-5.67	1.88	0.87
Income
Income Before Tax	-46.61	7.17	-42.53	-72.91	-30.60	-109.01	-92.88	-46.04	-21.10
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	-45.72	7.17	-61.32	-111.64	-30.60	-109.01	-92.88	-46.04	-21.10
Net Income - Continuous Operations	-45.72	7.17	-42.53	-111.64	-30.60	-109.01	-92.88	-46.04	-21.10
Net Income - Discontinued Operations	0.89	-	-18.79	-38.73	-	-	-	-	-
EBITDA	-42.43	13.53	-32.04	-54.51	-20.27	-101.05	-87.38	-43.68	-20.42
EBIT	-45.19	-26.16	-40.30	-62.31	-30.47	-109.83	-	-	-
Depreciation & Amortization	2.75	4.58	8.26	7.80	10.20	8.78	5.32	2.35	1.44
Earnings Per Share
Basic EPS	-4.00	1.00	-16.00	-38.00	-16.00	-63.00	-59.00	-28.00	-19.00
Diluted EPS	-4.00	1.00	-16.00	-38.00	-16.00	-63.00	-59.00	-28.00	-19.00
Basic Shares Outstanding	12.83	6.83	3.84	2.93	1.96	1.73	1.40	1.63	1.12
Diluted Shares Outstanding	12.83	6.88	3.84	2.93	1.96	1.73	1.40	1.63	1.12

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Precision BioSciences Financial Statements

What was Precision BioSciences's revenue in fiscal 2025?

Precision BioSciences reported revenue of $34.26M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 50.1% from $68.70M a year earlier.

Is Precision BioSciences profitable?

No. Precision BioSciences reported a net loss of $45.72M in fiscal 2025. In fiscal 2024 it earned $7.17M.

What is Precision BioSciences's operating margin?

Precision BioSciences's operating income was −$52.15M on revenue of $34.26M in fiscal 2025, an operating margin of -152.2%, compared with -38.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition